Case Report: Risk of virus infection after accidental blood inoculation from a multi-infected AIDS patient

Journal of Medical Virology

Volumn 84, Issue 6, 2012, Pages 897-900

  Berger, Annemarie ^a   Sturmer M ^a   Doerr, H W ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

CMV; HCV; HIV; Needlestick injury; Parvovirus B19

Indexed keywords

VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BLOOD SAMPLING; CASE REPORT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE TRANSMISSION; FOLLOW UP; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PARVOVIRUS B19; INFECTION RISK; MIXED INFECTION; PARVOVIRUS INFECTION; PHYLOGENY; SEROCONVERSION; VIREMIA; VIRUS INFECTION;

ADULT; BLOOD; BLOOD-BORNE PATHOGENS; HEPACIVIRUS; HEPATITIS C; HIV; HUMANS; INFECTIOUS DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; NEEDLESTICK INJURIES; PARVOVIRUS B19, HUMAN; PHYSICIANS; VIRAL LOAD;

CYTOMEGALOVIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; PARVOVIRUS;

EID: 84859777034     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23286     Document Type: Article

References (16)

1. Aberham C, Pendl C, Gross P, Zerlauth G, Gessner M. 2001. A quantitative, internally controlled real-time PCR Assay for the detection of parvovirus B19 DNA. J Virol Methods 92: 183- 191.
2. Berger A, Preiser W, Kachel HG, Stürmer M, Doerr HW. 2005. HBV reactivation after kidney transplantation. J Clin Virol 32: 162- 165.
3. Berger A, Rabenau H, Allwinn R, Doerr HW. 2008. Evaluation of the new ARCHITECT anti-HCV screening test under routine laboratory conditions. J Clin Virol 43: 158- 161.
4. Berger A, Giroglou T, Leutz A, Ogbomo H, Pfaff K, Teuber G, Cinatl J, van Laer D, Doerr HW. 2009. Measurements of HCV neutralizing antibodies and of HCV-specific CD4+ and CD8+ cells using hepatitis C virus pseudo-particles (HCVpp). J Clin Virol 46: 55- 60.
5. Berger A, Reitter A, Harter PN, Buxmann H, Allwinn R, Louwen F, Doerr HW. 2011. Problems and challenges in the diagnosis of vertical infection with human cytomegalovirus (CMV): Lessons from two accidental cases. J Clin Virol 51: 285- 288.
6. Gerna G, Lilleri D. 2006. Monitoring transplant patients for human cytomegalovirus: Diagnostic update. Herpes 13: 4- 11.
7. Preiser W, Brink NS, Ayliffe U, Peggs KS, Mackinnon S, Tedder RS, Garson JA. 2003. Development and clinical application of a fully controlled quantitative PCR assay for cell-free cytomegalovirus in human plasma. J Clin Virol 26: 49- 59.
8. Reinheimer C, Allwinn R, Doerr HW, Wittek M. 2010. Seroepidemiology of parvovirus B19 in the Frankfurt am Main area, Germany: Evaluation of risk factors. Infection 38: 381- 385.
9. Salzer HJ, Hoenigl M, Kessler HH, Stigler FL, Raggam RB, Rippel KE, Langmann H, Sprenger M, Krause R. 2011. Lack of risk-awareness and reporting behavior towards HIV infection through needlestick injury among European medical students. Int J Hyg Environ Health 214: 407- 410.
10. Sikora C, Chandran AU, Joffe AM, Johnson D, Johnson M. 2010. Population risk of syringe reuse: Estimating the probability of transmitting bloodborne disease. Infect Control Hosp Epidemiol 31: 748- 754.
11. Stürmer M, Berger A, Doerr HW. 2003. Modifications and substitutions of the RNA extraction module in the ViroSeq HIV-1 genotyping system version 2: Effects on sensitivity and complexity of the assay. J Med Virol 71: 475- 479.
12. Stürmer M, Berger A, Preiser W. 2004. HIV-1 genotyping: Comparison of two commercially available assays. Expert Rev Mol Diagn 4: 281- 291.
13. van Asten L, Verhaest I, Lamzira S, Hernandez-Aguado I, Zangerle R, Boufassa F, Rezza G, Broers B, Robertson JR, Brettle RP, McMenamin J, Prins M, Cochrane A, Simmonds P, Coutinho RA, Bruisten S. European and Italian Seroconverter Studies. 2004. Spread of hepatitis C virus among European injection drug users infected with HIV: A phylogenetic analysis. J Infect Dis 189: 292- 302.
14. van de Laar TJ, Langendam MW, Bruisten SM, Welp EA, Verhaest I, van Ameijden EJ, Coutinho RA, Prins M. 2005. Changes in risk behavior and dynamics of hepatitis C virus infections among young drug users in Amsterdam, the Netherlands. J Med Virol 77: 509- 518.
15. Wicker S, Cinatl J, Berger A, Doerr HW, Gottschalk R, Rabenau HF. 2008. Determination of risk of infection with blood-borne pathogens following a needlestick injury in hospital workers. Ann Occup Hyg 52: 615- 622.
16. Wittek M, Stürmer M, Doerr HW, Berger A. 2007. Molecular assays for monitoring HIV infection and antiretroviral therapy. Expert Rev Mol Diagn 7: 237- 246.